price target

The bank cited the positive one-year results of the high-risk Cohort A of its randomized partner trial for the Sapien transcatheter valve.

Edwards Lifesciences has a potential upside of 1.3% based on a current price of $85.48 and an average consensus analyst price target of $86.59.

Citigroup raised its target price for Edwards Lifesciences Corp (NYSE:EW) to $99 from $79 and reiterated its buy rating on the company.

The bank sees 2011 EPS of $1.45, vs. consensus estimates of $1.35 per share, and 2012 EPS of $1.76, in line with consensus estimates.

Citigroup initiated coverage of Nielsen Holdings NV (NYSE:NLSN) with a buy rating and $34 price target.

The bank sees 2011 EPS of $0.71 and 2012 EPS of $1.05.

Morgan Stanley initiated coverage of Nielsen Holdings NV (NYSE:NLSN) with an overweight rating and $30 price target.

Evergreen Solar has a potential upside of 76.2% based on a current price of $2 and an average consensus analyst price target of $3.52.

UBS lowered its price target for Evergreen Solar (NASDAQ:ESLR) to $1.75 from $2.70 and reiterated its sell rating.

Shares are up 1.17% to $25.85 in pre-market trading.

Comcast (CMCSA) is reportedly initiated with a Buy at Maxim with a price target of $34.

Terex has a potential upside of 8.2% based on a current price of $34.98 and an average consensus analyst price target of $37.87.

Terex should find initial support at its 50-day moving average (MA) of $33.15 and further support at its 200-day MA of $24.84.

UBS increased its price target for Terex Corporation (NYSE:TEX) to $40 from $31 and maintained its neutral rating.

Shares are up 5.81% to $2.73 in the pre-market session.

Orckit Communications (ORCT) is reportedly initiated with an Outperform at Rodman & Renshaw with a price target of $3.60.

Northrop Grumman has a potential upside of 9.6% based on a current price of $66.69 and an average consensus analyst price target of $73.07.

Northrop Grumman is currently below its 50-day moving average (MA) of $67.80 and should find support at its 200-day MA of $61.88.

UBS raised its price target for Northrop Grumman (NYSE:NOC) to $71 from $67 and maintained its neutral rating.

The bank views the company as disrupting the traditional business intelligence field with an easy to use but still powerful tool that has solved a long overdue problem. The company already has 18,000 small, medium and large busine

UBS initiated coverage of Qlik Technologies (NASDAQ:QLIK) with a buy rating and a $31 price target.

The firm cited valuation and lowered price target to $48 from $56.

Shares of Riverbed Technology (RVBD) are down 1.10% to $43.99 after ThinkEquity reportedly downgraded the company to Hold from Buy.